Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
04/2014
04/30/2014CN103751099A Bifonazole vaginal expansion suppository, as well as preparation method and detection method thereof
04/30/2014CN103751097A Ofloxacin vaginal swelling suppository, as well as preparation method and detection method thereof
04/30/2014CN103751096A Carboprost methylate vaginal swelling suppository, as well as preparation method and detection method thereof
04/30/2014CN103751095A Nonoxynol vaginal expansion suppository, as well as preparation method and detection method thereof
04/30/2014CN103751094A Ornidazole vaginal expansion suppository and preparation and detection methods thereof
04/30/2014CN103751092A Valnemulin hydrochloride enteric solid dispersion, as well as preparation method and application thereof
04/30/2014CN103751091A Process to minimize polymorphism
04/30/2014CN103751089A Secnidazole quick-release preparation
04/30/2014CN103750317A Andrias davidianus oil sustained-release dropping pill
04/30/2014CN103750301A Flavour composition capable of enhancing immunity
04/30/2014CN103142526B Dropping pills containing colloidal bismuth pectin
04/30/2014CN103142524B Calcitriol tablet and preparation method thereof
04/30/2014CN103142522B Etoposide tablet
04/30/2014CN103142497B Enteric granule of etoposide
04/30/2014CN103120794B Pharmaceutic adjuvant with collaborative work and anti-tumor application thereof
04/30/2014CN103070898B Salvia miltiorrhiza and panax notoginseng compound nano suspension
04/30/2014CN103054817B Vidarabine monophosphate pharmaceutical composition and preparation method thereof
04/30/2014CN102989006B Preparation method of silicon-nanowire-based medicinal carrier
04/30/2014CN102973489B Florfenicol solid dispersoid and preparation method thereof
04/30/2014CN102920674B Technology for preparing hydroxychloroquine sulfate tablets
04/30/2014CN102813639B Mebendazole soft capsule
04/30/2014CN102805870B Gold nano-spherical shell carrier with procedural gene drug release property and preparation method
04/30/2014CN102786675B Block copolymer and synthesis method thereof, and preparation method of nano particles
04/30/2014CN102764442B Method for preparing nano particles comprising protamine and genetic material
04/30/2014CN102755669B Preparation method and application of fibrin glue composite recombinant human bone morphogenetic protein-2 (rhBMP-2) microsphere
04/30/2014CN102755470B Cataplasm for treating cancer pain and preparation method thereof
04/30/2014CN102652734B Rabeprazole sodium enterosoluble micro-particles and preparation method thereof
04/30/2014CN102643358B Mango starch and preparation method thereof
04/30/2014CN102526075B Fat-soluble vitamin freeze-dried injection and preparation method thereof
04/30/2014CN102470115B Ophthalmic composition for silicone hydrogel contact lens
04/30/2014CN102380096B Medicine combination containing fusion protein for suppressing angiogenesis and application
04/30/2014CN102369009B Co-crystal of etravirine and nicotinamide
04/30/2014CN102212111B Micromolecule polypeptide and micromolecule polypeptide liposome as well as applications thereof
04/30/2014CN101985471B Folate-IgG conjugate as well as preparation method and application thereof
04/30/2014CN101880433B Thickened aqueous composition
04/30/2014CN101724075B Remodeling and glycoconjugation of peptides
04/30/2014CN101679021B Particulate drug delivery
04/30/2014CN101671407B Liquid dispersion polymer compositions, their preparation and their use
04/29/2014US8710187 Modified binding proteins inhibiting the VEGF-A receptor interaction
04/29/2014US8710105 Method of preparing enteric hard capsule and enteric hard capsule prepared thereby
04/29/2014US8710030 Phosphonate compounds
04/29/2014US8709998 Peptide vectors
04/29/2014US8709500 Drug delivery system
04/29/2014US8709489 Emulsions containing arylboronic acids and medical articles made therefrom
04/29/2014US8709484 Phospholipid-based powders for drug delivery
04/29/2014US8709482 Stabilised prostaglandin composition
04/29/2014US8709481 System for controlled release of an active principle and method for preparation
04/29/2014US8709476 Compositions of quaternary ammonium compounds containing bioavailability enhancers
04/29/2014US8709472 Bioactive agent-loaded heart-targeting nanoparticles
04/29/2014US8709463 Hemostatic devices and methods of making same
04/29/2014US8709460 Chemical method of making a suspension, emulsion or dispersion of pyrithione particles
04/29/2014US8709452 Synthetic bone grafts
04/29/2014US8709448 Anti-infective agents and uses thereof
04/29/2014US8709447 Compositions and methods for activating innate and allergic immunity
04/29/2014US8709430 Cancer treatment kits comprising therapeutic antibody conjugates that bind to aminophospholipids
04/29/2014CA2775393C Topical non-aqueous pharmaceutical formulations
04/29/2014CA2704778C Formulations for enhanced bioavailability of orally administered polar agents
04/29/2014CA2643714C Aryl/alkyl vinyl sulfone hyaluronic acid derivatives
04/29/2014CA2643145C Bifunctional resorcinol, thioresorcinol, and dithioresorcinol derivative metal chelating conjugates
04/29/2014CA2585976C Novel composition for easing human childbirth
04/29/2014CA2581196C Modifying surfaces of lactose serving as an auxiliary agent to be used for powder inhalants
04/29/2014CA2408571C Mammalian receptor proteins; related reagents and methods
04/24/2014WO2014063128A1 Cancer cell trap
04/24/2014WO2014063102A1 Biomimetic boundary lubricants for articular cartilage
04/24/2014WO2014062817A1 Topical steroid composition and method
04/24/2014WO2014062697A2 Drug delivery conjugates containing unnatural amino acids and methods for using
04/24/2014WO2014062696A1 Polymeric treatment compositions
04/24/2014WO2014062538A1 Polysaccharide-containing hydrogels, compositions, articles, and methods
04/24/2014WO2014062083A1 Pharmaceutical composition on the basis of phyto-nutrients with increased bioavailability, having anti-tumour activity, and method for producing said composition (alternatives)
04/24/2014WO2014062059A1 Enhanced nail penetrating composition
04/24/2014WO2014061332A1 Hyaluronic acid gel and method for producing same
04/24/2014WO2014060857A1 Pharmaceutical compositions of diclofenac or salts thereof
04/24/2014WO2014060855A1 Pharmaceutical compositions of diclofenac or salts thereof
04/24/2014WO2014060548A1 Anthocyanidin complex for the treatment of multiple myeloma
04/24/2014WO2014060539A1 New formulations comprising plant extracts
04/24/2014WO2014060529A1 Formulations comprising herbal extracts
04/24/2014WO2014060525A1 Stable formulations
04/24/2014WO2014060512A1 Fatty acid acylated amino acids for growth hormone delivery
04/24/2014WO2014060447A1 Fatty acid acylated d-amino acids for oral peptide delivery
04/24/2014WO2014060401A1 Coagulation factor vii polypeptides
04/24/2014WO2014060397A1 Factor vii conjugates
04/24/2014WO2014060365A1 Bispecific her2 ligands for cancer therapy
04/24/2014WO2014060324A1 Aripiprazole formulations
04/24/2014WO2014060150A1 Cosmetic or dermatological preparation for prophylaxis and/or treatment of atopic dermatitis
04/24/2014WO2014060138A1 Compositions comprising a silver salt of sucrose octasulfate and a potassium salt of sucrose octasulfate for protection of mucosal epithelia
04/24/2014WO2014059512A1 Oral drug delivery formulations
04/24/2014WO2014033158A3 Pcsk9 peptide vaccine
04/24/2014WO2012122422A3 Active agent prodrugs with heterocyclic linkers
04/24/2014WO2012122420A3 Opioid prodrugs with heterocyclic linkers
04/24/2014US20140114051 Block copolymers for stable micelles
04/24/2014US20140113977 Drug delivery agents comprising cyclodextrin covalently linked to a gemini surfactant, and pharmaceutical compositions comprising the same
04/24/2014US20140113975 Biodegradable block copolymeric compositions for drug delivery
04/24/2014US20140113971 Topical NSAID Compositions Having Sensate Component
04/24/2014US20140113961 Multi-arm polymeric alkanoate conjugates
04/24/2014US20140113926 Process for the production of an abuse-proofed solid dosage form
04/24/2014US20140113893 Highly Concentrated Stable Meloxicam Solutions for Needleless Injection
04/24/2014US20140113879 Block copolymers for stable micelles
04/24/2014US20140113875 Novel self-assembling drug amphiphiles and methods for synthesis and use
04/24/2014US20140113864 Injectable Depot Composition
04/24/2014US20140113862 Method for site-specific polyvalent display on polymers
1 ... 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 ... 1712